Market Access and Post-Market Activities (Part 3 of 3)

The journey of a new therapeutic drug coming to the marketplace is a complex and lengthy process that typically involves several key stages. The final part of our discussion focuses on the processes that occur after regulatory approval, including market access and post-market activities.

Continue reading

Industry News: New Study Shows DCT Methods Helped Lung Cancer Trial Enrollment as COVID Surged

Remote and flexible trial approaches have been a hallmark of clinical trials during the pandemic and are widely believed to have been the primary factor in keeping trials open and operating. There is evidence showing that such measures as telehealth visits, off-site diagnostic/monitoring procedures and remote consenting were at least partially responsible for the ability of lung cancer trials to weather the storm.

Continue reading